Key result
Estimated VO2max and METs from a 6-minute walk test predicted heart failure readmission within 30 days (C=0.750 and C=0.743, respectively; both p<0.001).
Why the study?
Heart disease imposes high costs, prompting interest in strategies to curb heart failure readmissions, particularly in developing countries.
Do VO2max and METs obtained from the 6-minute walk test predict heart failure readmission in patients with heart failure?
Cohort (n=93)
Do VO2max and METs obtained from the 6-minute walk test predict heart failure readmission in patients with heart failure?
Effect estimate: C-statistic 0.750
p-value: p=< 0.001
VO2max and METs derived from a pre-discharge 6-minute walk test can significantly predict 30-day heart failure readmission, offering a simple prognostic tool.
VO2max and METs from 6MWT were associated with 30-day HF readmission; supports further validation but should not yet change practice.
Background: Current statistics indicate that the overall cost of heart disease exceeds IDR 6.67 trillion per year. This growing concern has led researches on heart failure patient readmission in developing countries, and opened discussions on tactics to suppress hospital readmission rates. This study assesses the potential of VO2max and METs obtained from the 6-min walk test in predicting heart failure patient readmission. Methods: This seven-month prospective cohort study recruited patients with heart failure which then underwent the 6-min walk test before discharged. Walking distance, estimated VO2 max, and METs were calculated and recorded. Patients were then followed-up for 3 months to track readmissions under the same diagnosis during the research period. The correlation between VO2max and METs with patient readmission was assessed. Results: A total of 93 samples were included in this study. The results demonstrated that VO2max and METs correlate with incidence of heart failure readmission ≤30 days post discharge, with VO2max showing a moderate ability to predict patient readmissions with a cut-off of 14.5 mL/kgBW/minute (C = 0.750, p < 0.001), while METs showed a weak ability to predict readmissions with a cut-off of 3.8 (C = 0.743, p < 0.001). Conclusions: VO2 max and METs values acquired from 6MWT examination correlates with heart failure patient readmission ≤30 days. This knowledge can be used to prevent increased readmission rates, therefore hoping that it will be able to reduce the burden of treatment costs on heart failure patients.
No takes yet. Share an insight, caveat, or question.
Amir et al. (2022) conducted a cohort in heart failure (n=93). VO2max and METs from 6-minute walk test was evaluated on Heart failure readmission ≤30 days post discharge (C-statistic 0.750, p=< 0.001). Estimated VO2max and METs from a 6-minute walk test predicted heart failure readmission within 30 days (C=0.750 and C=0.743, respectively; both p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: